Gluvelop SMELLING SALTS

Manufacturer
Shenzhen Nanjun Technology Co., Ltd
Effective date
2025-07-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:06:55

Label at a glance#

ProductGluvelop SMELLING SALTS
Active ingredientAMMONIA
Label structure14 sections

Dosage and administration

Hold bottle 10-15 cm from nostrils and inhale slowly 1-2 times.

Storage and handling

Net Weight: 30g/1.06oz Expiry Date: 24 months(refer to batch number on bottle base) Storage: Store in a dark, dry place at 15-25°C.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Ammonia 15%

Purpose

OTC - PURPOSE SECTION

Inhalants

Use

INDICATIONS & USAGE SECTION

To prevent or treat fainang.

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

Do not use if you have respiratory conditions such as asthma or emphysema.
Discontinue use and consult a doctor if symptoms persist

When Using

OTC - WHEN USING SECTION

Avoid repeated inhalation. Do not use more than 2 times per application.

Stop Use

OTC - STOP USE SECTION

Stop use and ask a doctor if allergic reaction (rash, swelling) or persistent irritation occurs.

Ask Doctor

OTC - ASK DOCTOR SECTION

Do not use if you have respiratory conditions such as asthma or emphysema.
Discontinue use and consult a doctor if symptoms persist.

Keep Out Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Store in a cool, dry place inaccessible to children. Swallowing may cause poisoning.
If swallowed, seek immediate medical assistance or contact a Poison
Control Center(1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

Hold bottle 10-15 cm from nostrils and inhale slowly 1-2 times.

Other information

STORAGE AND HANDLING SECTION

Net Weight: 30g/1.06oz
Expiry Date: 24 months(refer to batch number on bottle base)
Storage: Store in a dark, dry place at 15-25°C.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Alcohol, Cotton,Lemon flavor

Questions

OTC - QUESTIONS SECTION

Ifswallowed,seekimmediatemedicalassistanceorcontactaPoison
ControlCenter(1-800-222-1222)

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1299889ammonia 15 % Nasal InhalantPSN1
1299889ammonia 150 MG/ML Nasal InhalantSCD1
1299889ammonia 0.045 GM per 0.3 ML Nasal InhalantSY1
1299889ammonia 0.3 ML Nasal InhalantSY1
1299889ammonia 15 % Nasal InhalantSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85590-002-01Gluvelop SMELLING SALTS30 g in 1 BOTTLEINHALANT301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85590-00285590-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
LIMONENE, (+/-)-9MC3I34447IACT
ALCOHOL3K9958V90MIACT
AMMONIA5138Q19F1XACTIB
COTTON70LDW53ROOIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gluvelop SMELLING SALTSSMELLING SALTSShenzhen Nanjun Technology Co., Ltd398c26ec-5eba-1202-e063-6294a90a76c92025-07-09WarningsExact identifier
ndc (package): 85590-002-01
ndc (product): 85590-002
ndc11 (package): 85590000201
spl id: 398c26ec-5ebb-1202-e063-6294a90a76c9
spl set id: 398c26ec-5eba-1202-e063-6294a90a76c9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.